AU3801193A - Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist - Google Patents
Use of interleukin-10 to induce the production of interleukin-1 receptor antagonistInfo
- Publication number
- AU3801193A AU3801193A AU38011/93A AU3801193A AU3801193A AU 3801193 A AU3801193 A AU 3801193A AU 38011/93 A AU38011/93 A AU 38011/93A AU 3801193 A AU3801193 A AU 3801193A AU 3801193 A AU3801193 A AU 3801193A
- Authority
- AU
- Australia
- Prior art keywords
- interleukin
- induce
- production
- receptor antagonist
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85455392A | 1992-03-20 | 1992-03-20 | |
US854553 | 1992-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3801193A true AU3801193A (en) | 1993-10-21 |
Family
ID=25319015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU38011/93A Abandoned AU3801193A (en) | 1992-03-20 | 1993-03-16 | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1081378A (en) |
AU (1) | AU3801193A (en) |
IL (1) | IL105101A0 (en) |
WO (1) | WO1993018783A1 (en) |
ZA (1) | ZA931942B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
JPH08510719A (en) * | 1993-02-01 | 1996-11-12 | ユニヴェルシテ リブル ドゥ ブリュッセル アンスティテュション ダンセニュマン ユニヴェルシテル | Use of a pharmaceutical composition containing an effective amount of interleukin-10, its analogs and / or agonists |
WO1998010792A1 (en) * | 1996-09-11 | 1998-03-19 | Prendergast Patrick T | Immune direction therapy |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US6544504B1 (en) | 1999-07-28 | 2003-04-08 | Schering Corporation | Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |
AU6376700A (en) * | 1999-07-28 | 2001-02-19 | Schering Corporation | Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |
WO2002066069A1 (en) * | 2001-02-20 | 2002-08-29 | Kansai Technology Licensing Organization Co., Ltd. | Remedies for inflammatory/tumor diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
JP2648236B2 (en) * | 1989-12-20 | 1997-08-27 | シェリング・コーポレーション | BCRF1 protein as interferon-gamma inhibitor |
PT600970E (en) * | 1991-08-06 | 2000-05-31 | Schering Corp | USE OF INTERLEUCIN-10 ANALOGUES OR ANTAGONISTS TO TREAT ENDOTOXIN-INDUCED TOXICITY OR SUPERANTIGENS |
-
1993
- 1993-03-16 WO PCT/US1993/002173 patent/WO1993018783A1/en active Application Filing
- 1993-03-16 AU AU38011/93A patent/AU3801193A/en not_active Abandoned
- 1993-03-18 ZA ZA931942A patent/ZA931942B/en unknown
- 1993-03-18 IL IL105101A patent/IL105101A0/en unknown
- 1993-03-19 CN CN93104408A patent/CN1081378A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1081378A (en) | 1994-02-02 |
IL105101A0 (en) | 1993-07-08 |
WO1993018783A1 (en) | 1993-09-30 |
ZA931942B (en) | 1993-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3102697A (en) | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase | |
AU4873193A (en) | Use of substituted benzimidazoles | |
AU5647686A (en) | Intermediates in the synthesis of acyltripeptide immunostimulants | |
EP0511013A3 (en) | Production of olefins | |
AU1608892A (en) | Use of acetals | |
AU3809093A (en) | System for digitizing the physical structure of an object | |
AU1784992A (en) | Subunit of the human interleukin-3 receptor | |
AU3236093A (en) | The use of ob-101 to treat inflammation | |
AU4377793A (en) | Alternative receptor therapy | |
AU1298392A (en) | Stimulating factor of the neu receptor | |
AU3801193A (en) | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist | |
AU1916192A (en) | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs | |
AU3235693A (en) | The use of ob-104 to treat inflammation | |
AUPM933094A0 (en) | Production of borides | |
AU8207587A (en) | Adjustable chair | |
GB9212410D0 (en) | Production of difluoromethane | |
AU1750695A (en) | Device to be used for the dropping of young | |
AU3284289A (en) | Human fc-gamma receptor | |
AU6569886A (en) | Amorphous benzimidazole anthelminitics | |
AU5627194A (en) | New use of 5-ht3 receptor antagonists | |
AU4156989A (en) | Leukotriene antagonist prodrugs | |
AU5734390A (en) | Improvements relating to joint support devices | |
AU2890484A (en) | Galenic forms of sulpiride for oral use | |
AU6017686A (en) | Preparation of disilane | |
AU2317988A (en) | Length adjustable walkingstick |